A Juno Therapeutics and Vir Biotechnology founder may be about to launch a new company with his family.
Dr. Larry Corey and two apparent family members, Dr. Daniel Corey and Jordan Corey, have started a new San Francisco-based immunotherapy company called CERo Therapeutics, according to SEC filings. The company raised $43 million in mid-November, per those filings. It has raised a total of $45 million since its incorporation in 2016.
Daniel Corey, a hematologist by training, is listed in state corporate filings as the company’s CEO; he is also listed as the company’s chief scientific officer in a recent conference agenda. Jordan Corey is the company’s chief financial officer, documents show.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect